The Evolving Use of Radioiodine Therapy in Differentiated Thyroid Cancer

Publisher： Karger

E-ISSN： 1423-0232|88|4|247-256

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.4, 2014-12, pp. : 247-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of radioiodine treatment for differentiated thyroid cancer on testis function

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 2, 2015-02 ,pp. : 295-299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multitargeted Kinase Inhibition in Metastatic Differentiated Radioiodine-Refractory Thyroid Cancer: A Look at New Therapeutic Options for a Rare Disease

By  

Oncology Research and Treatment, Vol. 39, Iss. 9, 2016-08 ,pp. : 548-552

Karger

Access to resources Recommend Favorite

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2749-2756

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radioiodine Treatment of Differentiated Thyroid Carcinoma: The Experience at Seoul National University Hospital

By  

Current Medical Imaging Reviews, Vol. 6, Iss. 1, 2010-02 ,pp. : 2-7

Bentham Science Publishers

Access to resources Recommend Favorite

Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy

By Mazokopakis Elias E.   Starakis Ioannis K.   Papadomanolaki Maria G.   Batistakis Antony G.   Papadakis John A.  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1369-1373

Informa Healthcare

Access to resources Recommend Favorite